Dermatitis News

LEO Pharma announced it has named Judit H. Nyirady, MD, MBA, as vice president of medical strategy and scientific affairs.

Wearing silk garments is not likely to lessen moderate to severe pediatric eczema or prevent infection, according to research published in PLOS Medicine.

Research finding that treatments for androgenetic alopecia varied in effectiveness between men and women was among April’s top-read articles on Healio.com/Dermatology.

The American Skin Association presented the David Martin Carter Mentor Award to Richard Edelson, MD, at the Society for Investigative Dermatology annual meeting in Portland, Oregon.

Sienna Biopharmaceuticals announced it has completed a $40 million, Series B financing to advance its diversified topical biotech pipeline.

Glenmark Pharmaceuticals announced that the FDA has cleared its investigational new drug application to initiate a first-in-human trial of GBR 310, a proposed biosimilar, to measure its pharmacokinetics in comparison to Xolair in healthy adults aged 18 to 65 years.

Study results finding that Xeljanz treatment of alopecia areata showed varied efficacy was among the top read articles of the past week on Healio.com/Dermatology.

Increased alcohol consumption was significantly associated with higher risk for rosacea in women, according to study results recently published in the Journal of the American Academy of Dermatology.

ORLANDO, Fla. — Racial and ethnic minority children experienced disparities in health care utilization and school attendance related to their atopic dermatitis, according to late-breaking research presented at the American Academy of Dermatology Annual Meeting.

TopMD announced that Jerald Sklar, MD, has been appointed to its board of directors.